This month, we're slicing up a feast of guidance and information on HIV treatment switching in the setting of viral suppression. ART, after all, is not a "set it and forget it" proposition: Even when viral load is persistently undetectable, patients and providers alike may come to see value in changing regimens. Brian R. Wood, M.D., of the University of Washington joins us at the proverbial dinner table to discuss the pros, the cons, and what the process of switching ART entails.   To learn more about this topic -- and many others of clinical importance -- visit Wood et al's National HIV Curriculum: https://www.hiv.uw.edu/     Please support us by visiting the episode transcript on TheBodyPro, which includes links to additional resources: https://www.thebodypro.com/podcast/hiv/future-hiv-care-switching-antiretroviral-therapy-brian-wood-oct-2025   This podcast is hosted and executively produced by Myles Helfand, TheBodyPro's executive editor; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

Ver todos los episodios